Survivin Antisense Oligonucleotides Effectively Radiosensitize Colorectal Cancer Cells in Both Tissue Culture and Murine Xenograft Models

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 1, 2008, Pages 247-255

  Rödel, Franz ^a   Frey, Benjamin ^b   Leitmann, Werner ^c   Capalbo, Gianni ^a   Weiss, Christian ^a   Rödel, Claus ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Animal model; Apoptosis; Radiosensitization; Rectal cancer; Survivin

Indexed keywords

CELL DEATH; CELL GROWTH; DOSIMETERS; MATHEMATICAL MODELS; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY;

ANIMAL MODELS; RADIOSENSITIZATION; RECTAL CANCER; SURVIVIN;

TISSUE CULTURE;

CASPASE 3; CASPASE 7; HISTONE H2AX; LY 2181308; MESSENGER RNA; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MICROARRAY ANALYSIS; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIZATION; RECTUM CANCER; TISSUE CULTURE; TUMOR BIOPSY; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 7; CELL CYCLE; CELL LINE, TUMOR; FEMALE; HISTONES; HUMANS; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; RADIATION TOLERANCE; RECTAL NEOPLASMS; RNA, MESSENGER; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 41749094285     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.02.011     Document Type: Article

References (37)

1. Dewey W.C., Ling C.C., and Meyn R.E. Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33 (1995) 781-796
2. Meyn R.E., Stephens L.C., and Milas L. Programmed cell death and radioresistance. Cancer Metastasis Rev 15 (1996) 119-131
3. Gudkov A.V., and Komarova E.A. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 3 (2003) 117-129
4. Rödel C., Grabenbauer G.G., Papadopoulos T., et al. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 294-303
5. Scott N., Hale A., Deakin M., et al. A histopathological assessment of the response of rectal adenocarcinoma to combination chemo-radiotherapy: Relationship to apoptotic activity, p53 and bcl-2 expression. Eur J Surg Oncol 24 (1998) 169-173
6. Rödel C., Haas J., Groth A., et al. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: Survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys 55 (2003) 1341-1347
7. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
8. Adams J.M., and Cory S. Bcl-2-regulated apoptosis: Mechanism and therapeutic potential. Curr Opin Immunol 19 (2007) 488-496
9. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (1997) 917-921
10. Sarela A.I., Verbeke C.S., Ramsdale J., et al. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer 86 (2002) 886-892
11. Kim P.J., Plescia J., Clevers H., et al. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362 (2003) 205-209
12. Kawasaki H., Toyoda M., Shinohara H., et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91 (2001) 2026-2032
13. Altieri D.C. Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm. J Cell Biochem 92 (2004) 656-663
14. Altieri D.C. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3 (2003) 46-54
15. Pennati M., Folini M., and Zaffaroni N. Targeting survivin in cancer therapy: Fulfilled promises and open questions. Carcinogenesis 28 (2007) 1133-1139
16. Capalbo G., Rödel C., Stauber R.H., et al. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther Onkol 183 (2007) 593-599
17. Rödel F., Hoffmann J., Grabenbauer G.G., et al. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Strahlenther Onkol 178 (2002) 426-435
18. Rödel C., Grabenbauer G.G., Papadopoulos T., et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21 (2003) 3098-3104
19. Zaffaroni N., Pennati M., and Daidone M.G. Survivin as a target for new anticancer interventions. J Cell Mol Med 9 (2005) 360-372
20. Schlingemann J., Habtemichael N., Ittrich C., et al. Patient-based cross-platform comparison of oligonucleotide microarray expression profiles. Lab Invest 85 (2005) 1024-1039
21. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
22. Hunter A.M., Lacasse E.C., and Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12 (2007) 1543-1568
23. LaCasse E.C., Baird S., Korneluk R.G., et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17 (1998) 3247-3259
24. Salvesen G.S., and Duckett C.S. IAP proteins: Blocking the road to death's door. Nat Rev Mol Cell Biol 3 (2002) 401-410
25. Li F., Ambrosini G., Chu E.Y., et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
26. Altieri D.C. Coupling apoptosis resistance to the cellular stress response: The IAP-Hsp90 connection in cancer. Cell Cycle 3 (2004) 255-256
27. Altieri D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8 (2008) 61-70
28. Rödel F., Hoffmann J., Distel L., et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65 (2005) 4881-4887
29. van 't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
30. Velculescu V.E., Madden S.L., Zhang L., et al. Analysis of human transcriptomes. Nat Genet 23 (1999) 387-388
31. Fortugno P., Beltrami E., Plescia J., et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A 100 (2003) 13791-13796
32. Lu B., Mu Y., Cao C., et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res 64 (2004) 2840-2845
33. Guan H.T., Xue X.H., Dai Z.J., et al. Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. World J Gastroenterol 12 (2006) 2901-2907
34. Pennati M., Binda M., Colella G., et al. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. J Invest Dermatol 120 (2003) 648-654
35. Kappler M., Taubert H., Bartel F., et al. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. Oncol Rep 13 (2005) 167-172
36. Kami K., Doi R., Koizumi M., et al. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 138 (2005) 299-305
37. Chakravarti A., Zhai G.G., Zhang M., et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23 (2004) 7494-7506